Documents

Filter documents Clear search

pdf icon

Joint BMS / FSRH / RCGP / RCOG framework for restoration of menopause services in response to COVID-19

File size: 1019kb | Date: 11 June 2020 | Covid-19 (Coronavirus) - PDF

The objective of this joint document produced by the British Menopause Society (BMS), the Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of General Practitioners (RCGP) and the Faculty of Sexual and Reproductive Healthcare (FSRH) is to provide guidance to clinical practitioners on the resumption and running of menopause services in the next phase of restoration of planned clinical services.

pdf icon

Progestogen-only injectables and anaphylactic reaction - Members Evidence Request June 2020

File size: 480kb | Date: 10 June 2020 | Covid-19 (Coronavirus) - PDF

Full Question: Regarding self administration at home of sayana press for someone who was starting an injectable for the first time - how safe is this (in relation to anaphylaxis) to be done at home for women who have not already had DMPA or sayana (bearing in mind anaphylaxis can sometimes only manifest itself after the second injection)?

pdf icon

Extended use of Implant and LNG-IUS during covid-19

File size: 197kb | Date: 5 June 2020 | Covid-19 (Coronavirus) - PDF

Full Question: Please can you explain why it is OK to use a Nexplanon® for 4 years and Mirena® for 6 years during Covid-19 but not under normal circumstances?

pdf icon

FSRH Position Restoration of SRH Services during Covid-19 and Beyond June 2020

File size: 155kb | Date: 5 June 2020 | Covid-19 (Coronavirus) - PDF

This guidance on restoration of SRH services is aimed at decision-makers, commissioners, service managers and healthcare professionals. It was developed in consultation with FSRH’s Scotland, Wales and Northern Ireland Committees. It provides recommendations on which services should be prioritised during restoration. It also outlines what has worked well during strict lockdown and should remain in place beyond the pandemic; for instance, the need for a variety of modalities of consultation to meet the SRH care needs of all, including the most vulnerable.

pdf icon

Combined hormonal contraception, COVID-19 and VTE risk - Members Evidence Request May 2020

File size: 459kb | Date: 4 June 2020 | Covid-19 (Coronavirus) - PDF

Full question: For women starting a CHC the first year seems to be when the highest risk of VTE. Is there some caution we should be taking with starting CHC at this current time when there is an increased risk of contracting Covid 19? Should we be more careful in those women with a higher BMI who may not be contraindicated to CHC? In smokers? Would it also be more of concern in those women who are shielding who may have more of a concern that covid may be more severe in them?